Table 1 Participant demographic and cancer characteristics
Characteristic | Undergoing Treatment (n = 258) | Completed Treatment (n = 783) | All (n = 1041) | p-valuea |
|---|---|---|---|---|
Sex | ||||
 Female | 161 (62.4) | 459 (58.7) | 620 (59.6) | 0.2926 |
 Male | 97 (37.6) | 323 (41.3) | 420 (40.4) |  |
Current age (years) | ||||
 < 20 | 2 (0.8) | 1 (0.1) | 3 (0.3) | <.0001 |
 20–29 | 7 (2.7) | 8 (1.0) | 15 (1.4) |  |
 30–39 | 43 (16.7) | 51 (6.5) | 94 (9.0) |  |
 40–49 | 72 (27.1) | 110 (14.1) | 182 (17.5) |  |
 50–59 | 75 (29.1) | 212 (27.1) | 287 (27.6) |  |
 60–69 | 39 (15.1) | 246 (31.4) | 285 (27.4) |  |
 70–79 | 16 (6.2) | 137 (17.5) | 153 (14.7) |  |
 > 80 | 4 (1.6) | 18 (2.3) | 22 (2.1) |  |
Country | ||||
 Canada | 112 (43.4) | 463 (59.1) | 575 (55.2) | <.0001 |
 USA | 126 (48.4) | 213 (27.2) | 339 (33.0) |  |
 UK | 11 (4.3) | 97 (12.4) | 108 (10.4) |  |
 Otherb | 9 (3.5) | 10 (1.3) | 19 (1.8) |  |
Ethnicity | ||||
 White | 198 (83.9) | 627 (88.9) | 825 (87.7) | 0.1073 |
 Hispanic | 3 (1.3) | 16 (2.3) | 19 (2.0) |  |
 Black | 1 (0.4) | 5 (0.7) | 6 (0.6) |  |
 Asian | 10 (4.2) | 23 (3.3) | 33 (3.5) |  |
 Native/Aboriginal | 4 (1.7) | 5 (0.7) | 9 (1.0) |  |
 Middle Eastern | 1 (0.4) | 2 (0.3) | 3 (0.3) |  |
 Otherc | 19 (8.1) | 27 (3.8) | 46 (4.9) |  |
Residence | ||||
 Urban | 80 (33.9) | 267 (38.0) | 347 (37.0) | 0.4127 |
 Suburban | 97 (41.1) | 257 (36.6) | 354 (37.7) |  |
 Rural | 59 (25.0) | 178 (25.4) | 237 (25.3) |  |
Education level | ||||
 High school or less | 42 (17.9) | 181 (25.8) | 223 (23.8) | 0.0137 |
 Postsecondary or more | 193 (82.1) | 521 (74.2) | 714 (76.2) |  |
Marital status | ||||
 Single, never married | 21 (8.8) | 45 (6.4) | 66 (7.0) | 0.2431 |
 Married/common-law | 186 (78.2) | 535 (75.9) | 721 (76.5) |  |
 Separated/divorced | 24 (10.1) | 92 (13.1) | 116 (12.3) |  |
 Widowed | 7 (2.9) | 33 (4.7) | 40 (4.2) |  |
Age at Diagnosis | ||||
 yCRC | 145 (56.2) | 282 (36.0) | 427 (41.0) | <.0001 |
 aCRC | 113 (43.8) | 501 (64.0) | 614 (59.0) |  |
CRC Type | ||||
 Colon | 164 (63.8) | 449 (57.7) | 613 (59.2) | 0.2159 |
 Rectal | 66 (25.7) | 228 (29.3) | 294 (28.4) |  |
 Both Sites | 27 (10.5) | 101 (13.0) | 128 (12.4) |  |
CRC Stage | ||||
 Stage 0 | 1 (0.4) | 16 (2.1) | 17 (1.6) | <.0001 |
 Stage I | 10 (3.9) | 95 (12.2) | 105 (10.1) |  |
 Stage II | 25 (9.7) | 166 (21.3) | 191 (18.4) |  |
 Stage III | 71 (27.5) | 341 (43.8) | 412 (39.7) |  |
 Stage IV | 136 (52.7) | 82 (10.5) | 218 (21.0) |  |
 Do not know | 15 (5.8) | 79 (10.1) | 94 (9.1) |  |
Number of Treatment Modalities | ||||
 One | 54 (21.0) | 214 (27.4) | 268 (25.8) | 0.0992 |
 More than one | 200 (77.8) | 563 (72.0) | 763 (73.4) |  |
 None | 3 (1.2) | 5 (0.6) | 8 (0.8) |  |
Treatment Typed,e | ||||
 Surgery | 196 (76.0) | 730 (93.2) | 926 (89.0) | <.0001 |
 Chemotherapy | 235 (91.1) | 558 (71.3) | 793 (76.2) | <.0001 |
 Radiation | 89 (34.5) | 286 (36.5) | 375 (36.0) | 0.5558 |
 Other | 11 (4.3) | 6 (0.8) | 17 (1.6) | 0.0001 |
 None | 3 (0.2) | 5 (0.6) | 8 (0.8) | 0.4030 |